dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Cardiology Homepage

Medical community finds ways to make TAVR safer for at-risk patients Improving outcomes with special procedures

New ultrasound tech could help detect pediatric congenital heart disease Visualizes structure and blood flow of babies' hearts

Mick Jagger resting after TAVR heart surgery The 75 year old rock star is reportedly recovering from the operation at New York Presbyterian

DHS warns some Medtronic implantable defibrillators vulnerable to hacking Software patch should resolve issue, recall not expected

New AI software identifies make and model of cardiac implants in seconds Speed up diagnosis and delivery of treatment for patients with faulty devices

Getting to the heart of cardiac ultrasound technology From premium systems to point of care, an expanding market

FDA gives thumbs-up to Genetesis MCG cardiac imaging system Measures magnetic fields produced by heart's electrical activity

Apple study suggests wearable technology may be useful in detecting atrial fibrillation May assist in stroke and hospitalization prevention

Echocardiogram should play role in patient selection for transcatheter mitral valve repair, says study New study highlighted at ACC

FDA gives green light for smallest, slimmest 3T CRM devices Extended battery lives, greater diagnostic and therapeutic capabilities

BIOTRONIK's Solia S ProMRI
pacing leads

BIOTRONIK announces availability of smallest MR-conditional pacing leads in U.S.

by Lauren Dubinsky , Senior Reporter
BIOTRONIK announced on Thursday that the smallest MR-conditional pacing lead in the U.S., its Solia S ProMRI, is now commercially available.

The lead received FDA approval on June 9 after its safety and efficacy was demonstrated in the Pre-Market Study phase of the SIELLO clinical study. The study enrolled 1,758 patients at 60 sites in the U.S. and implanted 3,220 Solia leads.

Story Continues Below Advertisement

New & Refurbished C-Arm Systems. Call 702.384.0085 Today!

KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent. With over 20 years in the medical equipment business we can help you fulfill your equipment needs



After 12 months, 100 percent of those who received an atrial Solia lead were adverse event-free and 99.6 percent who received a ventricular Solia lead were event-free. In addition, for patients with one or two Solia leads there was a 100 percent success rate for sensing and pacing at the 12-month mark.

"As physicians, we're focused on delivering the best possible patient care," Dr. Ulrika Birgersdotter-Green, director of pacemaker and ICD services at UC San Diego Health, told HCB News. "Cardiac innovations that help create a more personalized approach play a critical role in achieving positive outcomes."

The leads are available in three different lengths — 45, 53 and 60 centimeters. According to Birgersdotter-Green, there have been limitations in the lengths of leads available, but since patients have a wide range of anatomy types it’s important to have options.

Solia S ProMRI has a 5.6 French lead body diameter and a polyurethane coating over silicone to limit friction and make it easier for physicians to insert it through small vessels and intricate anatomy. Its soft distal segment is designed to help reduce stress and myocardial trauma.

"Patient anatomy is unique to each and every patient," she said. "For patients with small or complex vessels, complications such as vein occlusion are more likely to occur when using a lead with a wide diameter body. The smaller lead body helps maximize available blood flow and leave room for additional therapies."

BIOTRONIK’s ProMRI technology allows patients with pacemakers, implantable defibrillators, cardiac monitors and cardiac resynchronization therapy defibrillators to undergo an MR scan. According to the company, it has the broadest portfolio of MR-conditional cardiac devices on the market.

Since 2009, almost 600,000 leads in the Solia family have been implanted worldwide.

A couple of the other companies also offer MR-conditional leads. Medtronic’s Specify SureScan MR surgical leads received FDA approval in March, which are used with its spinal cord stimulation system and Boston Scientific’s INGEVITY MRI pacing leads scored approval in April.

Back to HCB News
  Pages: 1

Cardiology Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED